orphan drug
A drug designated for treatment of a rare condition or disease that typically affects fewer than 200,000 U.S. residents. When the FDA grants orphan drug status, a company may be qualified for special grants, tax breaks or other incentives to help defray research and production costs. Without these incentives, companies would be unable to profit from development of orphan drugs because of limited demand.